Challenges in vaccination of neonates, infants and young children

Michael E Pichichero1

  • 1Rochester General Hospital Research Institute, Rochester, NY 14621, United States of America.

Vaccine
|May 20, 2014
PubMed

Insights

Pediatric vaccination requires better understanding of infant immune responses to improve vaccine efficacy. Research focuses on antibody, B-cell, T-cell, and APC functions for stronger, longer-lasting immunity.

Area of Science:

  • Immunology
  • Pediatrics
  • Vaccinology

Background:

  • Neonates, infants, and young children receive multiple vaccine doses to prevent infections.
  • Despite high vaccine compliance, outbreaks of vaccine-preventable diseases persist globally.
  • Current pediatric vaccination strategies may require optimization for more robust and prolonged immunity.

Purpose of the Study:

  • To enhance understanding of pediatric immune responses to vaccine antigens.
  • To explore mechanisms for achieving improved and sustained immunity in young children.
  • To inform strategies for potentially reducing the number of primary and booster vaccinations.

Main Methods:

  • Review of recent research on infant and young child immunity following routine vaccinations.
  • Analysis of systemic antibody responses.
  • Evaluation of memory B-cell generation.
  • Assessment of CD4 T-cell responses.
  • Investigation of antigen-presenting cell (APC) function.

Main Results:

  • Data indicate a need for improved understanding of pediatric immune responses to vaccines.
  • Specific immune parameters like antibody levels, memory B-cells, CD4 T-cells, and APC function are crucial for vaccine effectiveness.
  • Variability in immune responses highlights potential targets for enhancement.

Conclusions:

  • Further research into pediatric immune responses is essential for optimizing vaccine strategies.
  • Targeting specific immune mechanisms could lead to more effective and potentially less frequent vaccination schedules.
  • Improving vaccine-induced immunity in infants and children is critical for global public health.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
405
Vaccinations01:51

Vaccinations

Overview
44.1K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
963
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
552
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K